Biotech Stock Surges on Covid Test Approval

SRNA call options are running at triple their usual volume

Deputy Editor
Jun 2, 2021 at 10:14 AM
facebook X logo linkedin

The shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) are up 6.1% to trade at $8.10 at last check, after news that the company has initiated the start of its Covid-19 test roll-out in Mexico. The rapid antigen test, Covi-Stix, was just approved by the Mexican government. 

On the charts, today's pop has SRNE breaking out past the 50-day moving average, which has been a source of overhead pressure since late February. The shares are now up 21% year-to-date, but remain a ways off their Aug. 10 five-year high of $19.39. 

Don't expect much from the brokerage bunch, as analysts are overwhelmingly bullish on Sorrento Therapeutics stock already. All four in coverage carry a "strong buy" rating, while the security's 12-month consensus price target of $27.50 is a whopping 239% premium to current levels. 

A short squeeze could keep the wind at the stock's back. Shorts have already started to jump ship, with short interest down 10% in the two most recent reporting period. Yet short interest still makes up an impressive 43.6% of the stock's available float and at the stock's average pace of trading, it would take over six days to buy back these bearish bets. 

Over in the options pits, calls are winning out after today's news. So far, 7,279 calls have crossed the tape, which is triple what's typically seen at this point. The weekly 6/4 8-strike call is the most popular today, followed by the 9-strike call in the same series. 

These options are attractively priced at the moment, per the stock's Schaeffer's Volatility Index (SVI) of 81%, which stands higher than just 5% of all other readings in its annual range. This implies that options players are pricing in relatively low volatility expectations. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI